(Circulation. 1997;96:2407-2413.)
© 1997 American Heart Association, Inc.
Articles |
Endothelial Dysfunction and Cardiorenal Injury in Experimental Salt-Sensitive Hypertension
Effects of Antihypertensive Therapy
From the Department of Medicine and Renal Section, Veterans Affairs Medical Center and University of Minnesota Medical School, Minneapolis, Minn.
Correspondence to Leopoldo Raij, MD, VA Medical Center, Nephrology/Hypertension Section, III J, 1 Veterans Dr, Minneapolis, MN 55417. E-mail raijx001{at}maroon.tc.umn.edu
Background Pharmacological control of hypertension has contributed to a significant decrease in cardiovascular morbidity and mortality, although the beneficial effect on cardiac and renal diseases has been far more modest than the reduction in stroke. The endothelium plays a crucial homeostatic role in the regulation of vascular tone thrombogenesis and vascular remodeling. We studied the relationship between endothelial dysfunction and cardiorenal injury in hypertensive rats and evaluated the effects of two classes of antihypertensive agents commonly used in the clinical setting, a diuretic (DIU) and an ACE inhibitor (CEI).
Methods and Results Dahl salt-sensitive rats (DS) given high dietary salt (4% NaCl) developed hypertension (systolic blood pressure [SBP], 218±9 versus 147±3 mm Hg in DS given 0.5% NaCl; P<.001), which was associated with impaired endothelium-dependent relaxations (EDRs) in aortic rings (ED50, 5.44±.18 versus 7.51±.10; P<.05) and mesenteric vessels (area under the curve, 299±11 versus 217±11 arbitrary units; P<.05). Hypertensive DS also demonstrated depressed nitric oxide synthase activity in the aorta (0.76±.15 versus 2.83±.17 nmol · min-1 · g protein-1; P<.05), left ventricular hypertrophy (0.43±.02 versus 0.29±.02 g ventricular weight/100 g body weight; P<.05), glomerular injury (histological injury score: 151±8 versus 11±2; P<.05), and increased urinary protein excretion (95±21 versus 25±5 mg/24 hours; P<.05). Treatment of DS rats with the CEI perindopril (4.56 mg · kg-1 · d-1) did not affect SBP (225±6 mm Hg) but modestly improved EDR (ED50: 6.07±.37; P<.05 versus hypertensive DS) as well as proteinuria and glomerular histology. Addition of the DIU indapamide (1.44 mg · kg-1 · d-1) normalized SBP (151±2 mm Hg; P<.05), EDR (ED50, 7.33±.08; P<.05), left ventricular hypertrophy (0.27±.01 g/100 g body weight; P<.05), and proteinuria (31±4 mg/24 hours; P<.05) and prevented glomerular injury (injury score: 30±2; P<.05). Monotherapy with DIU reduced SBP (175±3 mm Hg; P<.05) and normalized EDR and left ventricular hypertrophy but did not provide effective renal protection. In hypertensive DS, impaired EDR and left ventricular hypertrophy were positively correlated with SBP. In addition, we found a significant correlation between cardiac hypertrophy and endothelial dysfunction. Indeed, a hierarchical regression analysis revealed that impaired aortic EDR, and therefore decreased aortic compliance, positively contributed to left ventricular hypertrophy in addition to but independently of SBP [F(2, 37)=6.29; P=.004].
Conclusions These studies suggest a dissociation of the endothelial, cardiac, and renal effects of antihypertensive therapy in hypertension and may explain the variable success of antihypertensive regimens in treating hypertension while preventing cardiac and renal damage.
Key Words: cardiovascular diseases • endothelium • hypertension • kidney • nitric oxide
This article has been cited by other articles:
 |
|
 |
|
  F. Helle, C. Jouzel, C. Chadjichristos, S. Placier, M. Flamant, D. Guerrot, H. Francois, J.-C. Dussaule, and C. Chatziantoniou Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism Am J Physiol Renal Physiol, July 1, 2009; 297(1): F191 - F199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Zhou, I. H. Schuman, E. A. Jaimes, and L. Raij Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-{beta}, and fibronectin with concomitant increase in nitric oxide bioavailability Am J Physiol Renal Physiol, July 1, 2008; 295(1): F53 - F59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. You, C. Cochain, C. Loinard, J. Vilar, B. Mees, M. Duriez, B. I. Levy, and J.-S. Silvestre Combination of the Angiotensin-Converting Enzyme Inhibitor Perindopril and the Diuretic Indapamide Activate Postnatal Vasculogenesis in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 766 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matsuhisa, H. Otani, T. Okazaki, K. Yamashita, Y. Akita, D. Sato, A. Moriguchi, H. Imamura, and T. Iwasaka Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2473 - H2479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Jaimes, M.-S. Zhou, D. D. Pearse, L. Puzis, and L. Raij Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species Am J Physiol Renal Physiol, February 1, 2008; 294(2): F385 - F392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. G. Magalhaes, A. B. da Silveira, D. L. Mota, and A. D. O. Paixao Renal function in juvenile rats subjected to prenatal malnutrition and chronic salt overload Exp Physiol, May 1, 2006; 91(3): 611 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Placier, J.-J. Boffa, J.-C. Dussaule, and C. Chatziantoniou Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice Nephrol. Dial. Transplant., April 1, 2006; 21(4): 881 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-S. Zhou, I. H. Schulman, P. J. Pagano, E. A. Jaimes, and L. Raij Reduced NAD(P)H Oxidase in Low Renin Hypertension: Link Among Angiotensin II, Atherogenesis, and Blood Pressure Hypertension, January 1, 2006; 47(1): 81 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhou, L. C. Matavelli, H. Ono, and E. D. Frohlich Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR Am J Physiol Renal Physiol, October 1, 2005; 289(4): F871 - F879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Zhou, E. A. Jaimes, and L. Raij Atorvastatin Prevents End-Organ Injury in Salt-Sensitive Hypertension: Role of eNOS and Oxidant Stress Hypertension, August 1, 2004; 44(2): 186 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Harrison-Bernard, I. H. Schulman, and L. Raij Postovariectomy Hypertension Is Linked to Increased Renal AT1 Receptor and Salt Sensitivity Hypertension, December 1, 2003; 42(6): 1157 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Moreno, P. Dumas, M. L. Kaldunski, P. J. Tonellato, A. S. Greene, R. J. Roman, Q. Cheng, Z. Wang, H. J. Jacob, and A. W. Cowley Jr Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats Physiol Genomics, November 11, 2003; 15(3): 243 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Zhou, A. G. Adam, E. A. Jaimes, and L. Raij In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin II Hypertension, November 1, 2003; 42(5): 945 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fujii, L. Zhang, J. Igarashi, and H. Kosaka L-Arginine Reverses p47phox and gp91phox Expression Induced by High Salt in Dahl Rats Hypertension, November 1, 2003; 42(5): 1014 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Dobrian, S. D. Schriver, T. Lynch, and R. L. Prewitt Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity Am J Physiol Renal Physiol, October 1, 2003; 285(4): F619 - F628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Houghton, D. S. Strogatz, M. T. Torosoff, V. E. Smith, S. A. Fein, P. A. Kuhner, E. F. Philbin, and A. A. Carr African Americans With LVH Demonstrate Depressed Sensitivity of the Coronary Microcirculation to Stimulated Relaxation Hypertension, September 1, 2003; 42(3): 269 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gnudi, G. Viberti, L. Raij, V. Rodriguez, D. Burt, P. Cortes, B. Hartley, S. Thomas, S. Maestrini, and G. Gruden GLUT-1 Overexpression: Link Between Hemodynamic and Metabolic Factors in Glomerular Injury? Hypertension, July 1, 2003; 42(1): 19 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kobori, A. Nishiyama, Y. Abe, and L. G. Navar Enhancement of Intrarenal Angiotensinogen in Dahl Salt-Sensitive Rats on High Salt Diet Hypertension, March 1, 2003; 41(3): 592 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Smith, J. A. Payne, M. H. Sedeek, J. P. Granger, and R. A. Khalil Endothelin-Induced Increases in Ca2+ Entry Mechanisms of Vascular Contraction Are Enhanced During High-Salt Diet Hypertension, March 1, 2003; 41(3): 787 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. K. Johnson, W. Durante, K. J. Peyton, and R. A. Johnson Heme Oxygenase Inhibitor Restores Arteriolar Nitric Oxide Function in Dahl Rats Hypertension, January 1, 2003; 41(1): 149 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Silvestre, N. Kamsu-Kom, M. Clergue, M. Duriez, and B. I. Levy Very-Low-Dose Combination of the Angiotensin-Converting Enzyme Inhibitor Perindopril and the Diuretic Indapamide Induces an Early and Sustained Increase in Neovascularization in Rat Ischemic Legs J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1038 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. PERINOTTO, A. BIGGI, N. CARRA, A. ORRICO, G. VALMADRE, P. DALL'AGLIO, A. NOVARINI, and A. MONTANARI Angiotensin II and Prostaglandin Interactions on Systemic and Renal Effects of L-NAME in Humans J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1706 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Doucet, V. Richard, P. Mulder, J.-P. Henry, P. Schiavi, D. Guez, and C. Thuillez Effects of combination of low doses of angiotensin-converting enzyme inhibitor and diuretics on renal function in spontaneously hypertensive rats: comparison between acute and chronic treatment Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 107 - 111. [Abstract] [PDF]
|
|
|
|
|
|
J.-J. Boffa, Ying Lu, J.-C. Dussaule, and C. Chatziantoniou Improvements of renal lesions and function by angiotensin and endothelin receptor antagonism in nitric oxide-deficient rats Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S211 - S216. [Abstract] [PDF]
|
|
|
|
|
|
F. H. H. Leenen and B. Yuan Prevention of Hypertension by Irbesartan in Dahl S Rats Relates to Central Angiotensin II Type 1 Receptor Blockade Hypertension, March 1, 2001; 37(3): 981 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-J. Boffa, P.-L. Tharaux, J.-C. Dussaule, and C. Chatziantoniou Regression of Renal Vascular Fibrosis by Endothelin Receptor Antagonism Hypertension, February 1, 2001; 37(2): 490 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Giardina, G. M. Green, A. N. Rinewalt, J. P. Granger, and R. A. Khalil Role of Endothelin B Receptors in Enhancing Endothelium-Dependent Nitric Oxide-Mediated Vascular Relaxation During High Salt Diet Hypertension, February 1, 2001; 37(2): 516 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. BARTON, I. VOS, S. SHAW, P. BOER, L. V. D'USCIO, H.-J. GRÖNE, T. J. RABELINK, T. LATTMANN, P. MOREAU, and T. F. LÜSCHER Dysfunctional Renal Nitric Oxide Synthase as a Determinant of Salt-Sensitive Hypertension: Mechanisms of Renal Artery EndothelialDysfunction and Role of Endothelin for Vascular Hypertrophy andGlomerulosclerosis J. Am. Soc. Nephrol., May 1, 2000; 11(5): 835 - 845. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Kakoki, Y. Hirata, H. Hayakawa, A. Tojo, D. Nagata, E. Suzuki, K. Kimura, A. Goto, K. Kikuchi, T. Nagano, et al. Effects of Hypertension, Diabetes Mellitus, and Hypercholesterolemia on Endothelin Type B Receptor–Mediated Nitric Oxide Release From Rat Kidney Circulation, March 9, 1999; 99(9): 1242 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hayakawa, Y. Hirata, M. Kakoki, Y. Suzuki, H. Nishimatsu, D. Nagata, E. Suzuki, K. Kikuchi, T. Nagano, K. Kangawa, et al. Role of Nitric Oxide–cGMP Pathway in Adrenomedullin-Induced Vasodilation in the Rat Hypertension, February 1, 1999; 33(2): 689 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Raij Nitric Oxide in Hypertension: Relationship With Renal Injury and Left Ventricular Hypertrophy Hypertension, January 1, 1998; 31(1): 189 - 193. [Abstract] [Full Text] [PDF]
|
|